文献速递妇科生殖医学

自我报告子宫内膜异位症诊断的准确性:四个队列的比较

Validity of self-reported endometriosis: a comparison across four cohorts.
PubMed 文献 · Hum Reprod · 2021-01-01

该研究比较了四个国际队列中女性问卷自我报告的子宫内膜异位症诊断与医疗记录的一致性。结果显示,整体确认率为84%,当限定为自我报告曾获腹腔镜确诊时确认率高达97%。表明在大型人群研究中利用自我报告是有效的,尤其以腹腔镜确诊的自我报告作为病例定义时。

要点

  • 自我报告子宫内膜异位症整体医疗记录确认率为84%(72%–95%)。
  • 自我报告腹腔镜确诊者的医疗记录确认率高达97%(95%–100%)。
  • 仅42%的医疗记录包含病理报告,组织学确认率76%–100%。

核心结论

  • 女性自我报告子宫内膜异位症具有合理的准确性(>70%),当限定为报告腹腔镜确诊时准确性极高(>94%)。
  • 在需要大样本的子宫内膜异位症研究中,依赖自我报告是有效的,尤其以腹腔镜确诊的自我报告作为病例定义时。

研究设计与样本

  • 比较问卷报告的子宫内膜异位症与医疗记录记载,涉及四个国际队列:BWHS(1995-2013)、E3N(1990-2006)、GUTS(2005-2016)和NHSII(第一波1989-1993,第二波1995-2007)。
  • 共获取827名女性的医疗记录(BWHS 225名,E3N 168名,GUTS 85名,NHSII第一波132名,第二波217名),计算临床、手术和病理确认比例。

主要发现

  • 结合临床、手术和病理记录的整体确认率为84%(范围从BWHS的72%到GUTS的95%)。
  • 在自我报告腹腔镜确诊的女性中,医疗记录确认率总体为97%(范围从NHSII第二波的95%到NHSII第一波的100%)。
  • 仅42%的医疗记录包含病理报告,其中组织学确认率从GUTS的76%到NHSII第一波的100%。
  • AFS或rASRM分期记录见于NHSII第一波44%、NHSII第二波13%和GUTS 24%的手术记录;深部子宫内膜异位症的存在与否极少记录。

临床怎么用

  • 在临床研究和人群筛查中,可依赖自我报告的子宫内膜异位症诊断,尤其当自我报告包含腹腔镜确诊信息时。
  • 临床实践中应加强医疗记录的标准化,包括病理结果、AFS/rASRM分期和表型特征,以便于患者亚组分类。

局限性

  • 医疗记录摘录由各队列研究者分别进行,可能因摘录方案和解读差异引入错分偏倚。
  • AFS/rASRM分期、深部子宫内膜异位症及组织学结果的信息并非所有四个队列均可得。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How accurately do women report a diagnosis of endometriosis on self-administered questionnaires? SUMMARY ANSWER: Based on the analysis of four international cohorts, women self-report endometriosis fairly accurately with a > 70% confirmation for clinical and surgical records. WHAT IS KNOWN ALREADY: The study of complex diseases requires large, diverse population-based samples, and endometriosis is no exception. Due to the difficulty of obtaining medical records for a condition that may have been diagnosed years earlier and for which there is no standardized documentation, reliance on self-report is necessary. Only a few studies have assessed the validity of self-reported endometriosis compared with medical records, with the observed confirmation ranging from 32% to 89%. STUDY DESIGN, SIZE, DURATION: We compared questionnaire-reported endometriosis with medical record notation among participants from the Black Women's Health Study (BWHS; 1995-2013), Etude Epidémiologique auprès de femmes de la Mutuelle Générale de l'Education Nationale (E3N; 1990-2006), Growing Up Today Study (GUTS; 2005-2016), and Nurses' Health Study II (NHSII; 1989-1993 first wave, 1995-2007 second wave). PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants who had reported endometriosis on self-administered questionnaires gave permission to procure and review their clinical, surgical, and pathology medical records, yielding records for 827 women: 225 (BWHS), 168 (E3N), 85 (GUTS), 132 (NHSII first wave), and 217 (NHSII second wave). We abstracted diagnosis confirmation as well as American Fertility Society (AFS) or revised American Society of Reproductive Medicine (rASRM) stage and visualized macro-presentation (e.g. superficial peritoneal, deep endometriosis, endometrioma). For each cohort, we calculated clinical reference to endometriosis, and surgical- and pathologic-confirmation proportions. MAIN RESULTS AND THE ROLE OF CHANCE: Confirmation was high-84% overall when combining clinical, surgical, and pathology records (ranging from 72% for BWHS to 95% for GUTS), suggesting that women accurately report if they are told by a physician that they have endometriosis. Among women with self-reported laparoscopic confirmation of their endometriosis diagnosis, confirmation of medical records was extremely high (97% overall, ranging from 95% for NHSII second wave to 100% for NHSII first wave). Importantly, only 42% of medical records included pathology reports, among which histologic confirmation ranged from 76% (GUTS) to 100% (NHSII first wave). Documentation of visualized endometriosis presentation was often absent, and details recorded were inconsistent. AFS or rASRM stage was documented in 44% of NHSII first wave, 13% of NHSII second wave, and 24% of GUTS surgical records. The presence/absence of deep endometriosis was rarely noted in the medical records. LIMITATIONS, REASONS FOR CAUTION: Medical record abstraction was conducted separately by cohort-specific investigators, potentially introducing misclassification due to variation in abstraction protocols and interpretation. Additionally, information on the presence/absence of AFS/rASRM stage, deep endometriosis, and histologic findings were not available for all four cohort studies. WIDER IMPLICATIONS OF THE FINDINGS: Variation in access to care and differences in disease phenotypes and risk factor distributions among patients with endometriosis necessitates the use of large, diverse population samples to subdivide patients for risk factor, treatment response and discovery of long-term outcomes. Women self-report endometriosis with reasonable accuracy (>70%) and with exceptional accuracy when women are restricted to those who report that their endometriosis had been confirmed by laparoscopic surgery (>94%). Thus, relying on self-reported endometriosis in order to use larger sample sizes of patients with endometriosis appears to be valid, particularly when self-report of laparoscopic confirmation is used as the case definition. However, the paucity of data on histologic findings, AFS/rASRM stage, and endometriosis phenotypic characteristics suggests that a universal requirement for harmonized clinical and surgical data documentation is needed if we hope to obtain the relevant details for subgrouping patients with endometriosis. STUDY FUNDING/COMPETING INTEREST(S): This project was supported by Eunice Kennedy Shriver National Institute of Child Health and Development grants HD48544, HD52473, HD57210, and HD94842, National Cancer Institute grants CA50385, R01CA058420, UM1CA164974, and U01CA176726, and National Heart, Lung, and Blood Institute grant U01HL154386. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. AS, SM, and KT were additionally supported by the J. Willard and Alice S. Marriott Foundation. MK was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (#PIOF-GA-2011-302078) and is grateful to the Philippe Foundation and the Bettencourt-Schueller Foundation for their financial support. Funders had no role in the study design, conduct of the study or data analysis, writing of the report, or decision to submit the article for publication. LA Wise has served as a fibroid consultant for AbbVie, Inc for the last three years and has received in-kind donations (e.g. home pregnancy tests) from Swiss Precision Diagnostics, Sandstone Diagnostics, Kindara.com, and FertilityFriend.com for the PRESTO cohort. SA Missmer serves as an advisory board member for AbbVie and a single working group service for Roche; neither are related to this study. No other authors have a conflict of interest to report. Funders had no role in the study design, conduct of the study or data analysis, writing of the report, or decision to submit the article for publication. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Shafrir AL, Wise LA, Palmer JR, et al. Validity of self-reported endometriosis: a comparison across four cohorts. Hum Reprod. 2021. PMID: 33595055. doi:10.1093/humrep/deab012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。